A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout

TITLE:

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.

MEDICAL CONTION:

Gout

AGE:

18 Years to 75 Years

SEX/GENDER:

Male & Female

Volunteer UNIQUE opportunity

If you are interested in this particular trial, please click the button below to sign up.

OverviewS

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.

Study Details

Q

volunteer here

Interested in learning more?
Please submit the form below to get started.